Cargando…

Persistent disparities in antiretroviral treatment (ART) coverage and virological suppression across Europe, 2004 to 2015

Background: Direct comparisons between countries in core HIV care parameters are often hampered by differences in data collection. Aim: Within the EuroSIDA study, we compared levels of antiretroviral treatment (ART) coverage and virological suppression (HIV RNA < 500 copies/mL) across Europe and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laut, Kamilla, Shepherd, Leah, Radoi, Roxana, Karpov, Igor, Parczewski, Milosz, Mussini, Cristina, Maltez, Fernando, Losso, Marcelo, Chkhartishvili, Nikoloz, Elinav, Hila, Kovari, Helen, Blaxhult, Anders, Zangerle, Robert, Trofimova, Tatiana, Inglot, Malgorzata, Zilmer, Kai, Kuzovatova, Elena, Staub, Thérèse, Raben, Dorthe, Lundgren, Jens, Mocroft, Amanda, Kirk, Ole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152212/ https://www.ncbi.nlm.nih.gov/pubmed/29845931 http://dx.doi.org/10.2807/1560-7917.ES.2018.23.21.1700382

Ejemplares similares

Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression: A prospective cohort study
por: Llibre, Josep M., et al.
Publicado: (2016)

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens
por: Cozzi‐Lepri, A, et al.
Publicado: (2017)

Regional differences in self-reported HIV care and management in the EuroSIDA study
por: Grønborg Laut, Kamilla, et al.
Publicado: (2014)

Disparities in HIV clinic care across Europe: findings from the EuroSIDA clinic survey
por: Lazarus, Jeffrey V., et al.
Publicado: (2016)

Observational cohort study of rilpivirine (RPV) utilization in Europe
por: Cozzi-Lepri, Alessandro, et al.
Publicado: (2022)

The prevalence and predictive value of dipstick urine protein in HIV-positive persons in Europe
por: Mocroft, Amanda, et al.
Publicado: (2014)

Benchmarking HIV health care: from individual patient care to health care evaluation. An example from the EuroSIDA study
por: Podlekareva, Daria N, et al.
Publicado: (2012)

Feasibility and Effectiveness of Indicator Condition-Guided Testing for HIV: Results from HIDES I (HIV Indicator Diseases across Europe Study)
por: Sullivan, Ann K., et al.
Publicado: (2013)

Hyaluronic Acid Levels Predict Risk of Hepatic Encephalopathy and Liver-Related Death in HIV/Viral Hepatitis Coinfected Patients
por: Peters, Lars, et al.
Publicado: (2013)

Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study
por: Viard, JP, et al.
Publicado: (2010)

Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord
por: Smit, Colette, et al.
Publicado: (2015)

Trends in Cancer Incidence in Different Antiretroviral Treatment-Eras amongst People with HIV
por: Greenberg, Lauren, et al.
Publicado: (2023)

Phylodynamic Dispersal of SARS-CoV-2 Lineages Circulating across Polish–German Border Provinces
por: Serwin, Karol, et al.
Publicado: (2022)

The gut microbiome in human immunodeficiency virus infection
por: Zilberman-Schapira, Gili, et al.
Publicado: (2016)

Immuno-Virological Discordance and the Risk of Non-AIDS and AIDS Events in a Large Observational Cohort of HIV-Patients in Europe
por: Zoufaly, Alexander, et al.
Publicado: (2014)

Cascade of care among HIV patients diagnosed in 2013 in Georgia: Risk factors for late diagnosis and attrition from HIV care
por: Ruadze, Ekaterine, et al.
Publicado: (2017)

Long term effectiveness of once-daily unboosted atazanavir plus abacavir/lamivudine as a switch strategy in subjects with virological suppression
por: Llibre, Josep M, et al.
Publicado: (2014)

Malignant deep brain stimulator withdrawal syndrome
por: Azar, Jehad, et al.
Publicado: (2019)

Implementation of indicator condition guided HIV testing still lagging behind the evidence
por: Raben, Dorthe, et al.
Publicado: (2021)

HIV-1 integrase resistance among antiretroviral treatment naive and experienced patients from Northwestern Poland
por: Parczewski, Miłosz, et al.
Publicado: (2012)

Protective Effect of HLA-B*5701 and HLA-C -35 Genetic Variants in HIV-Positive Caucasians from Northern Poland
por: Leszczyszyn-Pynka, Magdalena, et al.
Publicado: (2015)

Characteristics of HIV-infected women and factors associated with HCV seropositivity in the Republic of Georgia
por: Chkhartishvili, Nikoloz, et al.
Publicado: (2011)

COVID-19-Associated Encephalopathy—Case Series and Clinical Considerations
por: Udzik, Jakub, et al.
Publicado: (2022)

Two pandemics intertwined around one patient: Interstitial pneumonia as the first presentation of HIV/AIDS, be it Pneumocystis jirovecii, cytomegalovirus, SARS-CoV2 or all?-A case report
por: Alsharif, Nuha, et al.
Publicado: (2023)

Assessment of quality of life in people living with HIV in Georgia
por: Karkashadze, Ekaterine, et al.
Publicado: (2016)

Tocilizumab Use among Patients Who Developed Pulmonary Embolism in the Course of Cytokine Release Storm and COVID-19 Pneumonia—A Retrospective Study
por: Chober, Daniel, et al.
Publicado: (2022)

Influence of Hepatitis C Coinfection and Treatment on Risk of Diabetes Mellitus in HIV-Positive Persons
por: Mocroft, Amanda, et al.
Publicado: (2020)

Increase in bone turnover markers in HIV patients treated with tenofovir disoproxil fumarate combined with raltegravir or efavirenz()
por: Oster, Yonatan, et al.
Publicado: (2020)

Prevalence and Structure of HIV-1 Drug Resistance to Antiretrovirals in the Volga Federal District in 2008–2019
por: Peksheva, Olga, et al.
Publicado: (2022)

HIV-1 Subtype D Infections among Caucasians from Northwestern Poland—Phylogenetic and Clinical Analysis
por: Parczewski, Miłosz, et al.
Publicado: (2012)

Transmitted drug resistance to rilpivirine among antiretroviral-naïve patients living with HIV from northern Poland
por: Parczewski, Miłosz, et al.
Publicado: (2014)

Temporal increase in HIV-1 non-R5 tropism frequency among antiretroviral-naive patients from northern Poland
por: Parczewski, Milosz, et al.
Publicado: (2014)

Transmitted HIV drug resistance and subtype patterns among blood donors in Poland
por: Parczewski, Miłosz, et al.
Publicado: (2021)

Influence of HLA-B*5701 on 20 year survival rate among patients living with HIV
por: Aksak-Wąs, Bogusz Jan, et al.
Publicado: (2021)

Correction: Influence of HLA-B*5701 on 20 year survival rate among patients living with HIV
por: Aksak-Wąs, Bogusz Jan, et al.
Publicado: (2022)

Regional Differences in AIDS and Non-AIDS Related Mortality in HIV-Positive Individuals across Europe and Argentina: The EuroSIDA Study
por: Reekie, Joanne, et al.
Publicado: (2012)

Community Vs. hospital HIV testing sites in Jerusalem, Israel - who’s tested and who’s at risk?
por: Atias, Dor, et al.
Publicado: (2020)

Mismatch between physicians and family members views on communications about patients with chronic incurable diseases receiving care in critical and intensive care settings in Georgia: a quantitative observational survey
por: Chikhladze, Nana, et al.
Publicado: (2016)

The prevalence of hyperglycemia and its impact on mortality among people living with HIV in Georgia
por: Borkowska, Tea, et al.
Publicado: (2022)

Effect of remdesivir on mortality and the need for mechanical ventilation among hospitalized patients with COVID-19: real-world data from a resource-limited country
por: Metchurtchlishvili, Revaz, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h8nlg859656hck6k0u0u220dqd